Literature DB >> 33801177

Role of C5aR1 and C5L2 Receptors in Ischemia-Reperfusion Injury.

Carlos Arias-Cabrales1, Eva Rodriguez-Garcia1, Javier Gimeno2, David Benito3, María José Pérez-Sáez1, Dolores Redondo-Pachón1, Anna Buxeda1, Carla Burballa1, Marta Crespo1, Marta Riera3, Julio Pascual1.   

Abstract

The role of C5a receptors (C5aR1 and C5L2) in renal ischemia-reperfusion injury (IRI) is uncertain. We generated an in vitro model of hypoxia/reoxygenation with human proximal tubule epithelial cells to mimic some IRI events. C5aR1, membrane attack complex (MAC) and factor H (FH) deposits were evaluated with immunofluorescence. Quantitative polymerase chain reaction evaluated the expression of C5aR1, C5L2 genes as well as genes related to tubular injury, inflammation, and profibrotic pathways. Additionally, C5aR1 and C5L2 deposits were evaluated in kidney graft biopsies (KB) from transplant patients with delayed graft function (DGF, n = 12) and compared with a control group (n = 8). We observed higher immunofluorescence expression of C5aR1, MAC and FH as higher expression of genes related to tubular injury, inflammatory and profibrotic pathways and of C5aR1 in the hypoxic cells; whereas, C5L2 gene expression was unaffected by the hypoxic stimulus. Regarding KB, C5aR1 was detected in the apical and basal membrane of tubular epithelial cells, whereas C5L2 deposits were observed in endothelial cells of peritubular capillaries (PTC). DGF-KB showed more frequently diffuse C5aR1 staining and C5L2 compared to controls. In conclusion, C5aR1 expression is increased by hypoxia and IRI, both in vitro and in human biopsies with an acute injury. C5L2 expression in PTC could be related to endothelial cell damage during IRI.

Entities:  

Keywords:  C5a receptors; complement system; delayed graft function; ischemia-reperfusion injury; kidney transplant

Year:  2021        PMID: 33801177      PMCID: PMC7957510          DOI: 10.3390/jcm10050974

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  43 in total

Review 1.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

Review 2.  Clinical promise of next-generation complement therapeutics.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Rev Drug Discov       Date:  2019-07-19       Impact factor: 84.694

3.  Relevance of KDPI value and acute rejection on kidney transplant outcomes in recipients with delayed graft function - a retrospective study.

Authors:  Carlos E Arias-Cabrales; María José Pérez-Sáez; Dolores Redondo-Pachón; Anna Buxeda; Carla Burballa; Xavier Duran; Marisa Mir; Marta Crespo; Julio Pascual
Journal:  Transpl Int       Date:  2020-06-15       Impact factor: 3.782

4.  Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury.

Authors:  Brandon Renner; Viviana P Ferreira; Claudio Cortes; Ryan Goldberg; Danica Ljubanovic; Michael K Pangburn; Matthew C Pickering; Stephen Tomlinson; Amanda Holland-Neidermyer; Derek Strassheim; V Michael Holers; Joshua M Thurman
Journal:  Kidney Int       Date:  2011-05-04       Impact factor: 10.612

5.  Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury.

Authors:  Felix Poppelaars; Maaike B van Werkhoven; Juha Kotimaa; Zwanida J Veldhuis; Albertina Ausema; Stefan G M Broeren; Jeffrey Damman; Julia C Hempel; Henri G D Leuvenink; Mohamed R Daha; Willem J van Son; Cees van Kooten; Ronald P van Os; Jan-Luuk Hillebrands; Marc A Seelen
Journal:  FASEB J       Date:  2017-04-10       Impact factor: 5.191

Review 6.  Chronic renal allograft injury: early detection, accurate diagnosis and management.

Authors:  Julio Pascual; Maria J Pérez-Sáez; Marisa Mir; Marta Crespo
Journal:  Transplant Rev (Orlando)       Date:  2012-08-17       Impact factor: 3.943

7.  Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney.

Authors:  Maaike B van Werkhoven; Jeffrey Damman; Mohamed R Daha; Christina Krikke; Harry van Goor; Willem J van Son; Jan-Luuk Hillebrands; Marcory C R F van Dijk; Marc A J Seelen
Journal:  Mol Immunol       Date:  2012-09-06       Impact factor: 4.407

8.  Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation.

Authors:  Dorottya K de Vries; Pieter van der Pol; Gerritje E van Anken; Danielle J van Gijlswijk; Jeffrey Damman; Jan H Lindeman; Marlies E J Reinders; Alexander F Schaapherder; Cees van Kooten
Journal:  Transplantation       Date:  2013-03-27       Impact factor: 4.939

Review 9.  Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies.

Authors:  Gwendolyn M P Diepenhorst; Thomas M van Gulik; C Erik Hack
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

10.  Membrane Attack Complex and Factor H in Humans with Acute Kidney Injury.

Authors:  Eva Rodríguez; Javier Gimeno; Carlos Arias-Cabrales; Clara Barrios; Dolores Redondo-Pachón; María José Soler; Marta Crespo; Adriana Sierra-Ochoa; Marta Riera; Julio Pascual
Journal:  Kidney Blood Press Res       Date:  2018-10-31       Impact factor: 2.687

View more
  1 in total

Review 1.  Role of Complement System in Kidney Transplantation: Stepping From Animal Models to Clinical Application.

Authors:  Ruochen Qi; Weijun Qin
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.